Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Dec;1(2):151-156.
doi: 10.1016/j.jdin.2020.07.009. Epub 2020 Dec 22.

Use of biologics in the era of COVID-19: Where do we stand?

Young Bin Lee  1 , Seung Phil Hong  1
Affiliations

Use of biologics in the era of COVID-19: Where do we stand?

Young Bin Lee et al. JAAD Int. 2020 Dec.
No abstract available

PubMed Disclaimer

References

    1. Lebwohl M., Rivera-Oyola R., Murrell D.F. Should biologics for psoriasis be interrupted in the era of COVID-19? J Am Acad Dermatol. 2020;82(5):1217–1218. - PMC - PubMed
    1. Wan M.T., Shin D.B., Winthrop K.L. The risk of respiratory tract infections and symptoms in psoriasis patients treated with IL-17-pathway inhibiting biologics: a meta-estimate of pivotal trials relevant to decision-making during the COVID-19 pandemic. J Am Acad Dermatol. 2020;83(2):677–679. - PMC - PubMed
    1. Carugno A., Gambini D.M., Raponi F. COVID-19 and biologics for psoriasis: a high-epidemic area experience - Bergamo, Lombardy, Italy. J Am Acad Dermatol. 2020;83(1):292–294. - PMC - PubMed
    1. Pacha O., Sallman M.A., Evans S.E. COVID-19: a case for inhibiting IL-17? Nat Rev Immunol. 2020;20(6):345–346. - PMC - PubMed
    1. Toniati P., Piva S., Cattalini M. Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: a single center study of 100 patients in Brescia, Italy. Autoimmun Rev. 2020;19(7):102568. - PMC - PubMed